FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

36510711000001103: Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    111634101000001118 Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    111634201000001113 Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status false Inferred relationship Existential restriction modifier
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none false Inferred relationship Existential restriction modifier
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets Is a Senna 7.5mg tablets 60 tablet false Inferred relationship Existential restriction modifier
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets Has AMP Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) false Inferred relationship Existential restriction modifier
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets Has basis of strength substance Senna false Inferred relationship Existential restriction modifier 1
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets Has basis of strength substance Sennoside B false Inferred relationship Existential restriction modifier
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets Has presentation strength numerator value 7.5 false Inferred relationship Existential restriction modifier 1
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 1
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets Has presentation strength denominator unit Tablet false Inferred relationship Existential restriction modifier 1
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets Has precise active ingredient Senna false Inferred relationship Existential restriction modifier 1
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets Has specific active ingredient Sennoside false Inferred relationship Existential restriction modifier
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets Has dispensed dose form Tablet false Inferred relationship Existential restriction modifier
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Sennoside B false Inferred relationship Existential restriction modifier
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets Legal category General sales list false Inferred relationship Existential restriction modifier
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
    Sennosides 7.5mg tablets (Alissa Healthcare Research Ltd) 60 tablet 3 x 20 tablets Is a Actual medicinal product pack false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start